Physician profile
Noah Michael Eger
NPI 1043280134
$18,068.60
in general payments reported to CMS, 2019-2025
26 companies · $895 in 2025
The $895 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,677 · 2020: $1,312 · 2021: $3,507 · 2022: $2,041 · 2023: $2,670 · 2024: $967 · 2025: $895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,747 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,747.09 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,785.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $7,705.45 | 2019-2025 | Precision 1, Total30, Dailies Total1 |
| Coopervision INC. | $4,369.95 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $2,873.11 | 2019-2024 | Acuvue |
| Bausch & Lomb Americas INC. | $837.33 | 2022-2025 | Miebo, Infuse, Xiidra |
| Optovue, INC. | $319.57 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $296.43 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $269.10 | 2019-2024 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $209.63 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $185.33 | 2024-2025 | Xdemvy |
| Lkc Technologies, INC. | $159.16 | 2023-2024 | |
| Horizon Therapeutics Plc | $120.79 | 2022 | |
| Kala Pharmaceuticals, INC. | $119.00 | 2020-2021 | |
| Apellis Pharmaceuticals, INC. | $114.30 | 2023 | Syfovre |
| Biotissue Holdings INC. | $70.31 | 2022-2025 | |
| Allergan, INC. | $62.98 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $60.01 | 2022 | |
| Abbvie INC. | $55.70 | 2022-2023 | Lumigan, Vuity |
| Harrow Eye, LLC | $49.66 | 2024 | Vevye |
| Abb Con-Cise Optical Group LLC | $42.65 | 2019-2022 | |
| Shire North American Group INC | $36.50 | 2019 | |
| Thea Pharma INC. | $23.49 | 2024 | Iyuzeh |
| Carl Zeiss Meditec USA, INC. | $20.01 | 2023 | Clarus |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Eyevance Pharmaceuticals LLC | $18.50 | 2022 | |
| Dompe US, INC. | $17.61 | 2025 | Oxervate |
| Alcon Research LLC | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noah Eger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.